Olema Pharmaceuticals Inc (NASDAQ: OLMA) on Monday, plunged -9.67% from the previous trading day, before settling in for the closing price of $10.45. Within the past 52 weeks, OLMA’s price has moved between $7.68 and $16.77.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of -8.23%. With a float of $49.58 million, this company’s outstanding shares have now reached $57.29 million.
In an organization with 74 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 85.67%, operating margin of -7213.69%, and the pretax margin is -6511.62%.
Olema Pharmaceuticals Inc (OLMA) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Olema Pharmaceuticals Inc is 13.47%, while institutional ownership is 88.12%. The most recent insider transaction that took place on Aug 01 ’24, was worth 35,796,000. In this transaction 10% Owner of this company sold 2,400,000 shares at a rate of $14.91, taking the stock ownership to the 783,118 shares. Before that another transaction happened on Jul 29 ’24, when Company’s Director sold 4,066 for $15.58, making the entire transaction worth $63,348. This insider now owns 752,217 shares in total.
Olema Pharmaceuticals Inc (OLMA) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -8.23% per share during the next fiscal year.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Trading Performance Indicators
Olema Pharmaceuticals Inc (OLMA) is currently performing well based on its current performance indicators. A quick ratio of 7.10 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.19, a number that is poised to hit -0.65 in the next quarter and is forecasted to reach -2.63 in one year’s time.
Technical Analysis of Olema Pharmaceuticals Inc (OLMA)
Let’s dig in a bit further. During the last 5-days, its volume was 0.62 million. That was inferior than the volume of 0.73 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 67.78%. Additionally, its Average True Range was 0.83.
During the past 100 days, Olema Pharmaceuticals Inc’s (OLMA) raw stochastic average was set at 19.73%, which indicates a significant decrease from 54.22% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 82.30% in the past 14 days, which was higher than the 67.22% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.06, while its 200-day Moving Average is $11.71. However, in the short run, Olema Pharmaceuticals Inc’s stock first resistance to watch stands at $10.24. Second resistance stands at $11.04. The third major resistance level sits at $11.44. If the price goes on to break the first support level at $9.04, it is likely to go to the next support level at $8.64. The third support level lies at $7.84 if the price breaches the second support level.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Key Stats
Market capitalization of the company is 549.83 million based on 57,298K outstanding shares. Right now, sales total 0 K and income totals -96,660 K. The company made 0 K in profit during its latest quarter, and -34,560 K in sales during its previous quarter.
